cardio may 11 national
Post on 05-Apr-2018
219 Views
Preview:
TRANSCRIPT
-
7/31/2019 Cardio May 11 National
1/42
Cardiovascular SystemNational Charts
-
7/31/2019 Cardio May 11 National
2/42
Cardiovascular Index of National Charts
Spending on High Strength Statins vs all other Statins42Prescribing of and Spending on Nicorandil21
Prescribing of High Strength Statins vs all other Statins41Spending on Calcium-Channel Blockers20
Prescribing of and Spending on Inegy40Prescribing of Calcium-Channel Blockers19
Spending on Rosuvastatin Tablets by Strength39Spending on Angiotensin-ll Receptor Antagonists (incl combinations)18
Prescribing of Rosuvastatin Tablets by Strength38Prescribing of Angiotensin-ll Receptor Antagonists (incl combinations)17
Spending on Simvastatin Tablets by Strength37Spending on ACE-Inhibitors (including combinations)16
Prescribing of Simvastatin Tablets by Strength36Prescribing of ACE-Inhibitors (including combinations)15
Spending on Atorvastatin Tablets by Strength35ACE Inhibitors vs Angiotensin-II Receptor Antagonists - Spending14
Prescribing of Atorvastatin Tablets by Strength34ACE Inhibitors vs Angiotensin-II Receptor Antagonists - Prescribing13
Spending on Statins33Spending on Alpha-adrenoceptor Blocking Drugs12
Prescribing of Statins32Prescribing of Alpha-adrenoceptor Blocking Drugs11
Prescribing of and Spending on Ezetimibe31Spending on Beta-adrenoceptor Blocking Drugs (including combinations)10
Spending on Lipid-regulating Drugs (excluding Statins)30Prescribing of Beta-adrenoceptor Blocking Drugs (including combinations)9
Prescribing of Lipid-regulating Drugs (excluding Statins)29Prescribing of and Spending on Amiodarone8
Spending on Aspirin BNF 2.9 (E/C Tablets vs Other Formulations)28Prescribing of Spironolactone (strengths)7
Prescribing of Aspirin BNF 2.9 (E/C Tablets vs Other Formulations)27Spending on Potassium-sparing Diuretics6
Spending on Antiplatelets26Prescribing of Potassium-sparing Diuretics5
Prescribing of Antiplatelets25Spending on Thiazides and Related Diuretics4
Prescribing of and Spending on Warfarin24
Prescribing of Thiazides and Related Diuretics3
Spending on Peripheral Vasodilators23Cardiovascular - Index of National Charts2
Prescribing of Peripheral Vasodilators22Cardiovascular1
-
7/31/2019 Cardio May 11 National
3/42
Trends in Prescribing of Thiazides and Related Diureticsin General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
Dec-05
Mar-06
Jun-06
Sep-0
6
Dec-06
Mar-07
Jun-07
Sep-0
7
Dec-07
Mar-08
Jun-08
Sep-0
8
Dec-08
Mar-09
Jun-09
Sep-0
9
Dec-09
Mar-10
Jun-10
Sep-1
0
Dec-10
Quarter to
Item
s
Bendroflumethiazide Indapamide Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
4/42
Trends in Spending on Thiazides and Related Diureticsin General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
NIC
()
Bendroflumethiazide Indapamide Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
5/42
Trends in Prescribing of Potassium-sparing Diureticsin General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
Dec-0
5
Mar-0
6
Jun-0
6
Sep-0
6
Dec-0
6
Mar-0
7
Jun-0
7
Sep-0
7
Dec-0
7
Mar-0
8
Jun-0
8
Sep-0
8
Dec-0
8
Mar-0
9
Jun-0
9
Sep-0
9
Dec-0
9
Mar-1
0
Jun-1
0
Sep-1
0
Dec-1
0
Quarter to
Items
Spironolactone Amiloride Eplerenone Triamterene
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
6/42
Trends in Spending on Potassium-sparing Diureticsin General Practice in England
Copyright NHSBSA 2011
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
Dec-0
5
Mar-0
6
Jun-0
6
Sep-0
6
Dec-0
6
Mar-0
7
Jun-0
7
Sep-0
7
Dec-0
7
Mar-0
8
Jun-0
8
Sep-0
8
Dec-0
8
Mar-0
9
Jun-0
9
Sep-0
9
Dec-0
9
Mar-1
0
Jun-1
0
Sep-1
0
Dec-1
0
Quarter to
NIC()
Spironolactone Amiloride Eplerenone Triamterene
-
7/31/2019 Cardio May 11 National
7/42
Trends in Prescribing of Spironolactone Caps/Tabsin General Practice in England
Copyright NHSBSA 2011
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
400,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Ite
ms
25mg 50mg 100mg
-
7/31/2019 Cardio May 11 National
8/42
Trends in Prescribing of and Spending on Amiodaronein General Practice in England
Copyright NHSBSA 2011
0
50,000
100,000
150,000
200,000
250,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Ite
ms
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
800,000
900,000
1,000,000
NIC()
Items NIC ()
-
7/31/2019 Cardio May 11 National
9/42
Trends in Prescribing of Beta-adrenoceptor Blocking Drugs(including Combinations) in General Practice in England
Copyright NHSBSA 2011
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
Atenolol Bisoprolol Propranolol Metoprolol Sotalol
Carvedilol Nebivolol Combinations Others
-
7/31/2019 Cardio May 11 National
10/42
Trends in Spending on Beta-adrenoceptor Blocking Drugs(including Combinations) in General Practice in England
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
N
IC()
Atenolol Bisoprolol Propranolol Metoprolol Sotalol
Carvedilol Nebivolol Combinations Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
11/42
Trends in Prescribing of Alpha-adrenoceptor Blocking Drugsin General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
1,600,000
1,800,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
Doxazosin Prazosin Terazosin Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
12/42
Trends in Spending on Alpha-adrenoceptor Blocking Drugs inGeneral Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
16,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
NIC()
Doxazosin Prazosin Terazosin Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
13/42
% of Prescribing of ACE Inhibitors vs Angiotensin-II Receptor Antagonistsin General Practice in England
Copyright NHSBSA 2011
0%
20%
40%
60%
80%
100%
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
%o
fallitems
ACE Inhibitors Angiotensin-II Receptor Antagonists
-
7/31/2019 Cardio May 11 National
14/42
% of Spending on ACE Inhibitors vs Angiotensin-II Receptor Antagonistsin General Practice in England
Copyright NHSBSA 2011
0%
20%
40%
60%
80%
100%
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
%o
fN
IC()
ACE Inhibitors Angiotensin-II Receptor Antagonists
-
7/31/2019 Cardio May 11 National
15/42
Trends in Prescribing of ACE Inhibitors (including combinations)in General Practice in England
Copyright NHSBSA 2011
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
Ramipril Lisinopril Perindopril Enalapril Combinations Others
-
7/31/2019 Cardio May 11 National
16/42
Trends in Spending on ACE Inhibitors (including combinations)in General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
NIC()
Ramipril Lisinopril Perindopril Enalapril Combinations Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
17/42
Trends in Prescribing of Angiotensin-II Receptor Antagonists(including combinations) in General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
3,500,000
4,000,000
4,500,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Ite
ms
Candesartan Losartan Irbesartan Valsartan Olmesartan Combinations Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
18/42
Trends in Spending on Angiotensin-II Receptor Antagonists(including combinations) in General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
70,000,000
80,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
N
IC()
Candesartan Losartan Irbesartan Valsartan Olmesartan Combinations Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
19/42
Trends in Prescribing of Calcium-channel Blockersin General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
Amlodipine Felodipine Nifedipine
Diltiazem Lercanidipine Verapamil
Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
20/42
Trends in Spending on Calcium-channel Blockersin General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
70,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
NIC
()
Amlodipine Felodipine Nifedipine
Diltiazem Lercanidipine Verapamil
Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
21/42
Trends in Prescribing of and Spending on Nicorandilin General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
N
IC()
Items NIC
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
22/42
Trends in Prescribing of Peripheral Vasodilators and Related Drugsin General Practice in England
0
10,000
20,000
30,000
40,000
50,000
60,000
70,000
80,000
90,000
Dec-05
Mar-06
Jun-06
Sep-0
6
Dec-06
Mar-07
Jun-07
Sep-0
7
Dec-07
Mar-08
Jun-08
Sep-0
8
Dec-08
Mar-09
Jun-09
Sep-0
9
Dec-09
Mar-10
Jun-10
Sep-1
0
Dec-10
Quarter to
It
ems
Naftidrofuryl Oxalate Oxerutins Cilostazol Pentoxifylline Nicotinic Acid Derivatives Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
23/42
Trends in Spending on Peripheral Vasodilators and Related Drugsin General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
1,600,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
NIC
()
Naftidrofuryl Oxalate Oxerutins Cilostazol Pentoxifylline Nicotinic Acid Derivatives Others
Copyright NHSBSA 2011
-
7/31/2019 Cardio May 11 National
24/42
Trends in Prescribing of and Spending on Warfarinin General Practice in England
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
NIC()
Items NIC ()
Copyright NHSBSA 2011
T d i P ibi f A i l l D
-
7/31/2019 Cardio May 11 National
25/42
Trends in Prescribing of Antiplatelet Drugsin General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
Aspirin Clopidogrel Dipyridamole Others
Copyright NHSBSA 2011
T d i S di A ti l t l t D
-
7/31/2019 Cardio May 11 National
26/42
Trends in Spending on Antiplatelet Drugsin General Practice in England
0
10,000,000
20,000,000
30,000,000
40,000,000
50,000,000
60,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
NIC()
Aspirin Clopidogrel Dipyridamole Others
N.B The price held for Dipyridamole 200mg m/r caps was incorrect during the quarter to December 2009,which accounts for the inflated NIC for this period
Copyright NHSBSA 2011
Trends in Prescribing of Aspirin BNF 2.9
-
7/31/2019 Cardio May 11 National
27/42
g p(E/C Tablets vs Other Formulations)
in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
Others E/C
Copyright NHSBSA 2011
Trends in Spending on Aspirin BNF 2.9
-
7/31/2019 Cardio May 11 National
28/42
p g p(E/C Tablets vs Other Formulations)
in General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
16,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
N
IC()
Others E/C
Copyright NHSBSA 2011
Trends in Prescribing of Lipid-regulating Drugs (excluding Statins)
-
7/31/2019 Cardio May 11 National
29/42
Trends in Prescribing of Lipid-regulating Drugs (excluding Statins)in General Practice in England
Copyright NHSBSA 2011
0
100,000
200,000
300,000
400,000
500,000
600,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
Omega-3 Bezafibrate Fenofibrate Ciprofibrate Colestyramine Others
NB. Excluding Ezetimibe
Trends in Spending on Lipid-regulating Drugs (excluding Statins)
-
7/31/2019 Cardio May 11 National
30/42
Trends in Spending on Lipid-regulating Drugs (excluding Statins)in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
9,000,000
10,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
N
IC()
Omega-3 Bezafibrate Fenofibrate Ciprofibrate Colestyramine Others
NB. Excluding Ezetimibe
Copyright NHSBSA 2011
Trends in Prescribing of and Spending on Ezetimibe
-
7/31/2019 Cardio May 11 National
31/42
Trends in Prescribing of and Spending on Ezetimibein General Practice in England
0
100,000
200,000
300,000
400,000
500,000
600,000
700,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Ite
ms
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
NIC
()
Items NIC ()
Copyright NHSBSA 2011
T d i P ibi f St ti i G l P ti i E l d
-
7/31/2019 Cardio May 11 National
32/42
Trends in Prescribing of Statins in General Practice in England
0
2,000,000
4,000,000
6,000,000
8,000,000
10,000,000
12,000,000
14,000,000
16,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
Simvastatin Atorvastatin Pravastatin Rosuvastatin Others
Copyright NHSBSA 2011
T d i S di g St ti i G l P ti i E gl d
-
7/31/2019 Cardio May 11 National
33/42
Trends in Spending on Statins in General Practice in England
0
50,000,000
100,000,000
150,000,000
200,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
NIC()
Simvastatin Atorvastatin Pravastatin Rosuvastatin Others
Copyright NHSBSA 2011
Trends in Prescribing of Atorvastatin Tablets by Strength
-
7/31/2019 Cardio May 11 National
34/42
g y gin General Practice in England
0
200,000
400,000
600,000
800,000
1,000,000
1,200,000
1,400,000
1,600,000
1,800,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
I
tems
10mg 20mg 40mg 80mg
Copyright NHSBSA 2011
Trends in Spending on Atorvastatin Tablets by Strength
-
7/31/2019 Cardio May 11 National
35/42
in General Practice in England
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
30,000,000
35,000,000
40,000,000
45,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
N
IC()
10mg 20mg 40mg 80mg
Copyright NHSBSA 2011
Trends in Prescribing of Simvastatin Tablets by Strength
-
7/31/2019 Cardio May 11 National
36/42
in General Practice in England
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
10mg 20mg 40mg 80mg
Copyright NHSBSA 2011
Trends in Spending on Simvastatin Tablets by Strength
-
7/31/2019 Cardio May 11 National
37/42
in General Practice in England
Copyright NHSBSA 2011
0
5,000,000
10,000,000
15,000,000
20,000,000
25,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
NIC()
10mg 20mg 40mg 80mg
Trends in Prescribing of Rosuvastatin Tablets by Strengthi G l P i i E l d
-
7/31/2019 Cardio May 11 National
38/42
in General Practice in England
Copyright NHSBSA 2011
0
50,000
100,000
150,000
200,000
250,000
300,000
350,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
5mg 10mg 20mg 40mg
Trends in Spending on Rosuvastatin Tablets by Strengthi G l P ti i E l d
-
7/31/2019 Cardio May 11 National
39/42
in General Practice in England
Copyright NHSBSA 2011
0
1,000,000
2,000,000
3,000,000
4,000,000
5,000,000
6,000,000
7,000,000
8,000,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
NIC()
5mg 10mg 20mg 40mg
Trends in Prescribing of and Spending on Inegyin General Practice in England
-
7/31/2019 Cardio May 11 National
40/42
in General Practice in England
0
10,000
20,000
30,000
40,000
50,000
60,000
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
Items
0
500,000
1,000,000
1,500,000
2,000,000
2,500,000
3,000,000
NIC()
Items NIC
Copyright NHSBSA 2011
% of Prescribing of High Strength Statins (Atorvastatin 40mg / 80mg,Rosuvastatin 20mg / 40mg, Simvastatin 80mg and Inegy)
-
7/31/2019 Cardio May 11 National
41/42
g g g gyvs All Other Statins in General Practice in England
0%
20%
40%
60%
80%
100%
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
%o
fItems
All other Statins High Strength
Copyright NHSBSA 2011
% of Spending on High Strength Statins (Atorvastatin 40mg / 80mg,Rosuvastatin 20mg / 40mg, Simvastatin 80mg and Inegy)
-
7/31/2019 Cardio May 11 National
42/42
vs All Other Statins in General Practice in England
0%
20%
40%
60%
80%
100%
Dec-05
Mar-06
Jun-06
Sep-06
Dec-06
Mar-07
Jun-07
Sep-07
Dec-07
Mar-08
Jun-08
Sep-08
Dec-08
Mar-09
Jun-09
Sep-09
Dec-09
Mar-10
Jun-10
Sep-10
Dec-10
Quarter to
%o
fNIC()
All other Statins High Strength
Copyright NHSBSA 2011
top related